Die Therapie zytostatikabedingter Hämostasestörungen

Literatur
1 Barbui T, Rodeghiero F, Meli S, Dini E. Fatal pulmonary embolism und antithrom-bin III deficiency in adult lymphoblastic leukemia during L-asparaginase therapy. Acta Haemat 1983; 69: 188.
2 Begemann H, Rastetter J. Klinische Häma-tologie. Stuttgart - New York : Thieme; 1986. S. 526.
3 Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon M. Acute promyelocytic leukemia: Results of treatment with daunorubicin. Blood 1973; 41: 489.
4 Bettigole R.F, Himelstein E.S, Oettgen H.F. Hypofibrinogenemia due to L-Asparaginase: Studies of fibrinogen survival using autologous ¹³¹J-fibrinogen. Blood 1970; 35: 190.
5 Bick R.L, Fekete L.F, Wilson W.L. Adriamycin and fibrinolysis. Thrombos Res 1976; 8: 467.
6 Bick R.L, Fekete L.F, Murano G. Dauno-mycin and fibrinolysis. Thrombos Res 1976; 9: 201.
7 Brand A, Claas F.H.J, Falkenburg J.H.F. Blood component therapy in bone marrow transplantation. Sem Hematol 1984; 21: 141.
8 Brodsky J, Conroy J.F. The effects of chemotherapy on hemostasis. Cancer Chemotherapy 1972; 2: 85.
9 Collins A.J, Bloomfield C.D, Peterson B.A, McKenna R.W, Edson J.R. Acute promyelocyte leukemia: Management of the coagulopathy during daunorubicin-prednisone remission induction. Arch Intern Med 1978; 138: 1677.
10 Cordonnier C, Vernant J.P, Brun B, Heilmann M.G, Kuentz M, Bierling P, Farcet J.P, Rodet M, Duedari N, Imbert M, Jouault H, Mannoni P, Reyes F, Dreyfus B, Ro-chant H. Acute promyelocytic leukemia in 57 previously untreated patients. Cancer 1985; 55: 18.
11 Coune A. Coagulopathies in patients with tumors. In: Medical Complications in Cancer Patients. Klastersky J, Staquet M.J. (eds) New York: Raven Press; 1981: 15.
12 Cunningham I, Gee T, Kempin S, Clarkson B. Acute promyelocytic leukemia (APL): Ten years experience. Proc Am Soc Clin Oncol 1984; 3: 203.
13 Daly P.A, Schiffer C.A, Wiernick P.H. Acute promyelocytic leukemia: Clinical management of 15 patients. Am J Hematol 1980; 8: 347.
14 Deutsch E, Fischer M, Frischauf H, Nonetz N, Lechner K, Pesendorfer F, Stych H, Weissmann A. Blood coagulation changes under L-asparaginase therapy. In: Experimental and Clinical Effects of L-Asparaginase. Grundmann E, Oettgen H.F. (eds) Berlin, Heidelberg, New York : Springer; 1970: 331.
15 Deutsch E. Blutgerinnungsstörungen bei nichthämatologischen malignen Erkrankungen. Beitr Onkol 1982; 13: 276.
16 Drapkin R.L, Gee T.S, Dowling M.D, Arlin Z, McKenzie S, Kempin S, Clarkson B. Prophylactic heparin therapy in acute promyelocytic leukemia. Cancer 1978; 41: 2484.
17 Duquesnoy R.J, Anderson A.J, Tomasulo P.A. ABO incompatibility and platelet transfusions in alloimmunized thrombocytopenic patients. Blood 1979; 54: 595.
18 Eisenstaedt R. Blood component therapy in the treatment of platelet disorders. Sem Hematol 1986; 23: 1.
19 Gmür J, von Feiten A, Osterwalder B, Honegger H.P, Hörmann A, Sauter Ch, Deubelbeiss K, Berchthold W, Mataxas M, Scali G, Frick P.G. Delayed alloimmunization using random single donor platelet transfusions : A prospective study in thrombocytopenic patients with acute leukemia. Blood 1983; 62: 473.
20 Goldberg M.A, Ginsburg D, Mayer R.J, Stone R.M, Magnire M, Rosenthal D.S, Antin J.H. Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?. Blood 1987; 69: 187.
21 Gonault-Heilmann M, Chardon E, Sultan C, Josso F. The procoagulant factor of leukemia promyelocytes: demonstration of immunologic cross reactivity with human Grain Fissue factor. Brit J Haemat 1975; 30: 151.
22 Goodnough L.T, Saito H, Manni A, Jones P.K, Pearson O. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer 1984; 54: 1264.
23 Gordon S.G. Tumorprokoagulans, Gerinnung und Fibrinolyse bei malignen Erkrankungen. Hämostaseologie 1985; 5: 160.
24 Gralnick H.R, Bagley B.S, Abrell E. Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia. Am J Med 1972; 52: 167.
25 Gralnick H.R, Abrell E. Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukemia. Brit J Haemat 1973; 24: 89.
26 Kantarjian H.M, Keating M.J, Walters R.S, Estey E.H, McKredie K.B, Smith T.L, Dalton W.T, Trujillo J.M, Freireich E.J. Acute promyelocytic leukemia: The M.D. Anderson Hospital experience. Am J Med 1986; 80: 789.
27 Klener P, Kubisz P, Suranova J. Influence of cytotoxic drugs on platelet functions and coagulation. Thrombos Hemostas 1977; 37: 53.
28 Monto R.W, Talley R.W, Caldwell M.J. Observations on the mechanism of hemorrhagic toxicity in mithramycin therapy. Cancer Res 1969; 29: 697.
29 Murphy S. Platelet storage for transfusion. Semin Hematol 1985; 22: 165.
30 Olson R.E. Vitamin K-induced prothrombin formation antagonism by actinomycin D. Science 1964; 145: 926.
31 Rasche H, Dietrich M. Die Hämostasestörung der akuten Leukämie. Blut 1975; 30: 153.
32 Rasche H, Dietrich M. Hemostatic abnormalities associated with malignant diseases. Europ J Cancer 1977; 13: 1053.
33 Rasche H, Hoelzer D, Dietrich M, Pflieger H, Kurrle E. The coagulation defect in the L 5222 experimental rat leukemia. Leukemia Res 1977; 1: 171.
34 Rasche H. Prophylaxe venöser Thrombo-embolien bei hämatologischen Erkrankungen. Hämostaseologie 1981; 1: 160.
35 Rasche H. Hämostasedefekte durch Umsatzstörungen bei soliden Tumoren und malignen hämatologischen Systemerkrankungen. In: Handbuch der Inneren Medizin Bd. II/9. Heene D.L. (Hrsg) Berlin, Heidelberg: Springer; 1985. S650.
36 Rasche H. Gesichertes und Ungesichertes in der medikamentösen Thromboembolie-prophylaxe. Beitr Intensiv-Notfallmed 1987; 5: 1.
37 Robinson E.A.E. Single donor granulocytes and platelets. Clin Haematol 1984; 13: 185.
38 Ruggero D, Baccarani M, Guarini A, Gu-gliotta L, Gobbi M, Ricci P, Zaccaria A, Lauria F, Tomasini I, Fiachini M, Santucci M.A, Tura S. Acute promyelocytic leukemia: Results of therapy and analysis of 13 cases. Acta Hematol 1977; 58: 108.
39 Schiffer C.A, Dutcher J.P, Aisner J. A randomized trial of leukocyte depleted platelet transfusion to modify allo-immunization in patients with leukemia. Blood 1983; 62: 815.
40 Schwartz B.S, Williams E.C, Conlan M.G, Mosher D.F. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency. Ann Intern Med 1986; 105: 873.
41 Sintinicolaas K, Sizoo W, Hajie W.G, Abels J, Vriesendorp H.M, Stenfert W.F, Hop W.C.J, Lowenberg B. Delayed alloimmunization by random donor platelet transfusions. Lancet 1981; I: 750.
42 Slichter S.J, Harker L.A. Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood. Br J Haematol 1976; 34: 395.
43 Slichter S.J, Harker L.A. Separation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. Brit J Haematol 1976; 34: 403.
44 Slichter S.J. Optimum platelet concentrate preparation and storage. In: Current Concepts in Transfusion Therapy. Garatty G. (ed) Arlington, VA: American Association of Blood Banks; 1985: 1.
45 Snyder E.L, Koerne A.W, Kakiya R. Effect of mode of agitation on storage of platelet concentrates in PL-732 containers for five days. Vox Sang 1983; 44: 300.
46 Tigges F.J, Bruntsch U, Groos G, Gallmeier W.M. Mikroangiopathische hämolytische Anämie als Komplikation bei Mitomycin-C-Therapie. Dtsch Med Wochenschr 1982; 107: 142.
47 Vicariot M, Abgrall J.F, Dutel J.L. Anti-leuko-platelet alloimmunization in blood replacements. Do transfusions of platelets from single donors present an advantage over platelets from multiple donors?. Rev Fr Transfus Immunohematol 1984; 27: 35.
48 Wiernick P.H. Acute leukemias of adults. In: Cancer-Principles and Practice of Oncology. DeVita V.T, Hellman S, Rosenberg S.A. (eds) Philadelphia: JB Lippincott; 1985: 1711.
49 Wiesneth M. Transfusionsstrategie bei der Substitution mit Thrombozyten und Granulozyten. Beitr Infusionstherapie klin Ernähr (im Druck).
50 Wintrobe M.M, Lee G.R, Boggs D.R, Birhell T.C, Roerster J, Athens J.W, Lukens J.N. (eds) Clinical Hematology. Philadelphia: Lea and Febiger; 1981: 1226.